---
title: "Weekly Recap | Welltower Op +1.09%, consensus target above spot"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300192960.md"
description: "Welltower Op gained 1.09% this week to close at $231.37, while the S&P 500 rose 1.21%, leaving the stock about 0.12 percentage points behind the benchmark. Trading was choppy: the name opened Monday at $229.26 and climbed to $232.76, faded through Tuesday and Wednesday, pushed to $236.97 on Thursday, then touched $237.315 early Friday before slipping back to $231.37. Weekly amplitude was 3.84%, and average daily volume of 2.54 million shares came in roughly 4% below the 60-day median."
datetime: "2026-09-26T07:21:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300192960.md)
  - [en](https://longbridge.com/en/news/300192960.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300192960.md)
generator: "portal-rs"
---

# Weekly Recap | Welltower Op +1.09%, consensus target above spot

## The Week

Welltower Op gained 1.09% this week to close at $231.37, while the S&P 500 rose 1.21%, leaving the stock about 0.12 percentage points behind the benchmark. Trading was choppy: the name opened Monday at $229.26 and climbed to $232.76, faded through Tuesday and Wednesday, pushed to $236.97 on Thursday, then touched $237.315 early Friday before slipping back to $231.37. Weekly amplitude was 3.84%, and average daily volume of 2.54 million shares came in roughly 4% below the 60-day median.

## Key Events

Company news this week centred on the earnings calendar and rating changes. On Tuesday, Welltower announced the timing of its third-quarter 2026 results release, conference call and webcast, with the report due after market close on 26 October. Price action was mixed against peers: the stock underperformed REIT rivals on Tuesday, then showed clear relative strength on Thursday. JPMorgan took a contrarian stance on interest rates during the week and upgraded three REITs, lifting Welltower from neutral to overweight on 24 September.

## Analyst Ratings

Across 22 brokers covering the name, 12 rate it buy, 6 rate it overweight, and 4 rate it hold, with no underweight or sell ratings. The consensus recommendation is buy, and the consensus target price of $262.05 sits about 13.3% above the latest close. Targets range from $219 to $292, pointing to a wide spread of views. Within the REIT industry, Welltower ranks 15th out of 149 names by analyst rating.

## The Week Ahead

The macro calendar is busy next week. Monday 28 September brings the Dallas Fed manufacturing index, and Tuesday 29 September includes FHFA house prices, the Case Shiller 20-city index, JOLTS job openings and consumer confidence. On the company side, the next earnings release is due after market close on 26 October, with consensus estimates at EPS of $0.6166 and revenue of $3.746 billion.

## In Short

This week brought marginal changes on both the news and ratings fronts. Most brokers rate Welltower buy or overweight, and the consensus target sits above spot by about 13%, yet targets span from $219 to $292, pointing to a split view on the path forward. The shares rose 1.09%, a touch below the S&P 500, without forming a one-way trend through the week. The focus now turns to the late-October earnings print as a check on valuation and money flow.

*This article is generated by LongbridgeAI from market data, for information only and not investment advice.*

### Related Stocks

- [WELL.US](https://longbridge.com/en/quote/WELL.US.md)

## Related News & Research

- [Why Welltower stock topped the market on Thursday](https://longbridge.com/en/news/300087352.md)
- [Welltower (WELL) Rides A Strong Return Run, Is The Stock Fully Priced?](https://longbridge.com/en/news/298996024.md)
- [Polymarket Odds: Will MU, FDS Beat Earnings Tomorrow?](https://longbridge.com/en/news/300470494.md)
- [What's Going On With Oracle Stock Tuesday?](https://longbridge.com/en/news/300437295.md)
- [What Is Going on With Marvell Technology Stock on Tuesday?](https://longbridge.com/en/news/300460741.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**